Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€5.50
04.10.21
-
04.10.22
-1.36%
17.10.21

Risky Investment
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.60
04.10.21
-
04.10.22
-4.62%
16.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Valneva SE

Start price
Target price
Perf. (%)
€12.95
03.10.21
€20.00
03.10.22
15.83%
16.10.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€51.56
03.10.21
-
03.10.22
1.55%
17.10.21

Could be very worthwhile Investment >20% year
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€4.12
03.10.21
-
03.10.22
3.86%
17.10.21

Risky Investment
buy
Geratherm Medical AG

Start price
Target price
Perf. (%)
€9.46
03.10.21
-
03.10.22
-10.78%
04.06.22

Could be very worthwhile Investment >20% year
Omeros Corp.

Start price
Target price
Perf. (%)
€7.20
02.10.21
-
02.10.22
-53.29%
03.10.22

Probably not worthwhile Investment
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€9.50
01.10.21
-
01.10.22
-58.63%
13.03.22

buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.46
30.09.21
-
30.09.22
0.00%
02.10.21

Risky Investment
buy
Nicox S.A.

Start price
Target price
Perf. (%)
€3.19
29.09.21
€3.80
29.09.22
-46.37%
30.09.22

Could be worthwhile Investment >10% per year
buy
Deciphera Pharmaceuticals

Start price
Target price
Perf. (%)
€28.40
29.09.21
€40.00
31.12.24
-67.96%
05.11.21

Could be very worthwhile Investment >20% year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.40
29.09.21
€10.00
31.12.24
43.52%
11.10.21

Could be very worthwhile Investment >20% year
Editas Medicine Inc

Start price
Target price
Perf. (%)
€46.67
29.09.21
€35.00
31.10.22
-16.73%
29.09.21

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€312.00
28.09.21
-
28.09.22
-54.17%
28.09.22

buy
Insmed Inc.

Start price
Target price
Perf. (%)
€23.60
27.09.21
€40.00
31.12.23
-25.00%
08.05.23

Could be very worthwhile Investment >20% year
buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.36
26.09.21
-
26.09.22
14.15%
27.09.22

Could be worthwhile Investment >10% per year
buy
PhaseBio Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.62
25.09.21
€5.00
31.12.23
-97.42%
08.05.23

Could be very worthwhile Investment >20% year
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.55
20.09.21
€4.00
20.09.22
-13.87%
30.09.21

Good culture
Probably not worthwhile Investment
Below average Management
Little innovation
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.50
20.09.21
-
20.09.22
29.09%
21.09.21

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.84
20.09.21
€4.00
20.09.22
-13.38%
02.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
20.09.21
€4.00
20.09.22
-22.69%
22.10.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€34.22
20.09.21
€60.00
31.12.23
-88.71%
08.05.23

Could be very worthwhile Investment >20% year
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment